Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis
Status:
Not yet recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
•This study will be a randomized, controlled, parallel study. .To demonstrate the efficacy of
empagliflozin and clinical improvement in patients of mild to moderate UC using the Montreal
classification of severity of ulcerative colitis.